Lifetime Costs of Septal Reduction Therapies are Substantially Lower Compared to Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy

被引:0
|
作者
Daaboul, Yazan [1 ]
Rowin, Ethan [2 ]
Maron, Martin [2 ]
Kimmelstiel, Carey [1 ]
机构
[1] Tufts Med Ctr, Boston, MA USA
[2] Lahey Hosp & Med Ctr, Burlington, MA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
TCT-355
引用
收藏
页码:B144 / B144
页数:1
相关论文
共 50 条
  • [21] Impact of Race and Ethnicity on Use and Outcomes of Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy
    Patlolla, Sri Harsha
    Schaff, Hartzell V.
    Nishimura, Rick A.
    Eleid, Mackram F.
    Geske, Jeffrey B.
    Ommen, Steve R.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (01):
  • [22] Costs and Healthcare Resource Utilization for Obstructive Hypertrophic Cardiomyopathy With Septal Reduction Therapy br
    Butzner, Michael
    Maron, Martin S.
    Sarocco, Phil
    Teng, Chia-Chen
    Stanek, Eric
    Tan, Hiangkiat
    Robertson, Laura A.
    JOURNAL OF INVASIVE CARDIOLOGY, 2022, 34 (12): : E866 - E872
  • [23] Radiofrequency septal reduction in symptomatic hypertrophic obstructive cardiomyopathy
    Crossen, Karl
    Jones, Marsha
    Erikson, Christopher
    HEART RHYTHM, 2016, 13 (09) : 1885 - 1890
  • [24] Induced septal infarction nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy
    Kuhn, HJ
    CIRCULATION, 1998, 97 (07) : 708 - 709
  • [25] Discrepant Volume-cost Relationship Of Septal Reduction Therapies For The Treatment Of Obstructive Hypertrophic Cardiomyopathy
    Maltibi, Ahmed
    Ghanem, Fares
    Masri, Ahmad
    JOURNAL OF CARDIAC FAILURE, 2023, 29 (04) : 639 - 640
  • [26] Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy
    Hegde, Sheila M.
    Lester, Steven J.
    Solomon, Scott D.
    Michels, Michelle
    Elliott, Perry M.
    Nagueh, Sherif F.
    Choudhury, Lubna
    Zemanek, David
    Zwas, Donna R.
    Jacoby, Daniel
    Wang, Andrew
    Ho, Carolyn Y.
    Li, Wanying
    Sehnert, Amy J.
    Olivotto, Iacopo
    Abraham, Theodore P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (25) : 2518 - 2532
  • [27] Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy
    Desai, Milind Y.
    Owens, Anjali
    Geske, Jeffrey B.
    Wolski, Kathy
    Naidu, Srihari S.
    Smedira, Nicholas G.
    Cremer, Paul C.
    Schaff, Hartzell
    McErlean, Ellen
    Sewell, Christina
    Li, Wanying
    Sterling, Lulu
    Lampl, Kathy
    Edelberg, Jay M.
    Sehnert, Amy J.
    Nissen, Steven E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (02) : 95 - 108
  • [28] Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy - Outcome in the first series of patients
    Knight, C
    Kurbaan, AS
    Seggewiss, H
    Henein, M
    Gunning, M
    Harrington, D
    Fassbender, D
    Gleichmann, U
    Sigwart, U
    CIRCULATION, 1997, 95 (08) : 2075 - 2081
  • [29] MANAGEMENT OF HYPERTENSION IN PATIENTS WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY TREATED WITH MAVACAMTEN
    Reza, Nosheen
    Marzolf, Amy B.
    Hornsby, Nicole
    de Feria, Alejandro
    Owens, Anjali Tiku
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 564 - 564
  • [30] Percutaneous Radiofrequency Septal Reduction for Hypertrophic Obstructive Cardiomyopathy in Children
    Sreeram, Narayanswami
    Emmel, Mathias
    de Giovanni, Joseph V.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (24) : 2501 - 2510